Loading clinical trials...
Loading clinical trials...
Early Stage Identification and Engagement to Reduce the Duration of Untreated Psychosis: Evaluating the Impact of Screening and Systematic Communication
Conditions
Interventions
Screening Method (SM)
Screening and Communication Method (SCM)
Locations
1
United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Start Date
May 1, 2023
Primary Completion Date
April 30, 2027
Completion Date
April 30, 2027
Last Updated
July 20, 2025
NCT07226895
NCT05968560
NCT06650943
NCT04007510
NCT06909422
NCT07196423
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions